392 related articles for article (PubMed ID: 16251485)
1. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
[TBL] [Abstract][Full Text] [Related]
2. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.
Marin-Kuan M; Cavin C; Delatour T; Schilter B
Toxicon; 2008 Aug; 52(2):195-202. PubMed ID: 18649906
[TBL] [Abstract][Full Text] [Related]
3. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.
Cavin C; Delatour T; Marin-Kuan M; Holzhäuser D; Higgins L; Bezençon C; Guignard G; Junod S; Richoz-Payot J; Gremaud E; Hayes JD; Nestler S; Mantle P; Schilter B
Toxicol Sci; 2007 Mar; 96(1):30-9. PubMed ID: 17110534
[TBL] [Abstract][Full Text] [Related]
4. Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration.
Arbillaga L; Vettorazzi A; Gil AG; van Delft JH; García-Jalón JA; López de Cerain A
Toxicol Appl Pharmacol; 2008 Jul; 230(2):197-207. PubMed ID: 18417182
[TBL] [Abstract][Full Text] [Related]
5. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
Adler M; Müller K; Rached E; Dekant W; Mally A
Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
[TBL] [Abstract][Full Text] [Related]
6. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays.
Luhe A; Hildebrand H; Bach U; Dingermann T; Ahr HJ
Toxicol Sci; 2003 Jun; 73(2):315-28. PubMed ID: 12700408
[TBL] [Abstract][Full Text] [Related]
7. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model.
Jennings P; Weiland C; Limonciel A; Bloch KM; Radford R; Aschauer L; McMorrow T; Wilmes A; Pfaller W; Ahr HJ; Slattery C; Lock EA; Ryan MP; Ellinger-Ziegelbauer H
Arch Toxicol; 2012 Apr; 86(4):571-89. PubMed ID: 22124623
[TBL] [Abstract][Full Text] [Related]
9. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
Rached E; Hard GC; Blumbach K; Weber K; Draheim R; Lutz WK; Ozden S; Steger U; Dekant W; Mally A
Toxicol Sci; 2007 Jun; 97(2):288-98. PubMed ID: 17344223
[TBL] [Abstract][Full Text] [Related]
10. Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicity.
Schilter B; Marin-Kuan M; Delatour T; Nestler S; Mantle P; Cavin C
Food Addit Contam; 2005; 22 Suppl 1():88-93. PubMed ID: 16332626
[TBL] [Abstract][Full Text] [Related]
11. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
[TBL] [Abstract][Full Text] [Related]
12. A review on ochratoxin A transcriptomic studies.
Vettorazzi A; van Delft J; López de Cerain A
Food Chem Toxicol; 2013 Sep; 59():766-83. PubMed ID: 23747715
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney.
Petrik J; Zanić-Grubisić T; Barisić K; Pepeljnjak S; Radić B; Ferencić Z; Cepelak I
Arch Toxicol; 2003 Dec; 77(12):685-93. PubMed ID: 13680094
[TBL] [Abstract][Full Text] [Related]
15. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A.
Mantle P; Kulinskaya E; Nestler S
Food Addit Contam; 2005; 22 Suppl 1():58-64. PubMed ID: 16332623
[TBL] [Abstract][Full Text] [Related]
16. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents.
Mally A; Dekant W
Mol Nutr Food Res; 2009 Apr; 53(4):467-78. PubMed ID: 19072886
[TBL] [Abstract][Full Text] [Related]
17. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
[TBL] [Abstract][Full Text] [Related]
18. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
19. MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Appl Pharmacol; 2007 Oct; 224(2):174-81. PubMed ID: 17651772
[TBL] [Abstract][Full Text] [Related]
20. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
